AI assistant
Sending…
Hoth Therapeutics, Inc. — Director's Dealing 2020
Sep 9, 2020
34935_dirs_2020-09-09_3d6d22b0-eee2-4f4b-9726-5b1846addbdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2020-09-08
Reporting Person: Johns Stefanie (Chief Scientific Officer)
More from Hoth Therapeutics, Inc.
Board/Management Information
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Regulatory Filings
2026
Jun 2
Capital/Financing Update
2026
May 28
Share Issue/Capital Change
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6